Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide

被引:64
|
作者
Kuhre, Rune Ehrenreich
Albrechtsen, Nicolai Jacob Wewer
Hartmann, Bolette
Deacon, Carolyn F.
Hoist, Jens Juul
机构
[1] Univ Copenhagen, Ctr Basic Metab Res, Novo Nordisk Fdn, DK-2200 Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, DK-2200 Copenhagen, Denmark
关键词
Incretin hormones; Glucagon-like peptide-1; Glucose-dependent insulinotropic peptide; ELISA; RIA; GASTRIC-INHIBITORY POLYPEPTIDE; COMMERCIALLY AVAILABLE ASSAYS; NEUTRAL ENDOPEPTIDASE-24.11; GLP-1; PLASMA; DEGRADATION; SPECIFICITY; PORCINE; CELL; GIP;
D O I
10.1016/j.jdiacomp.2014.12.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The two incretin hormones, glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), are secreted from the gastrointestinal tract in response to meals and contribute to the regulation of glucose homeostasis by increasing insulin secretion. Assessment of plasma concentrations of GLP-1 and GIP is often an important endpoint in both clinical and preclinical studies and, therefore, accurate measurement of these hormones is important. Here, we provide an overview of current approaches for the measurement of the incretin hormones, with particular focus on immunological methods. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:445 / 450
页数:6
相关论文
共 50 条
  • [1] Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas
    Seino, Yutaka
    Yabe, Daisuke
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (02) : 108 - 130
  • [2] Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus
    Cypryk, Katarzyna
    Vilsboll, Tina
    Nadel, Iwona
    Smyczynska, Joanna
    Holst, Jens Juul
    Lewinski, Andrzej
    GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (01) : 58 - 62
  • [3] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
  • [4] Glucose-dependent insulinotropic peptide and glucagon-like peptide-1 in impaired glucose tolerant states: Role of the duodenum
    Theodorakis, M
    Carlson, O
    Michopoulos, S
    Doyle, M
    Juhaszova, M
    Petraki, K
    Egan, J
    DIABETES, 2003, 52 : A77 - A77
  • [5] Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonists
    Tuzun, Dilek
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2022, 26 (02) : 92 - 96
  • [6] Mechanisms underlying glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion
    Reimann, Frank
    Gribble, Fiona M.
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 : 13 - 19
  • [7] Clinical Significance of Autoantibody Measurement for Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 in the Plasma
    Yamagata, Hiroki
    Onishi, Shunichiro
    Yoshida, Tomohiko
    Hiwasa, Takaki
    Takemoto, Minoru
    DIABETES, 2022, 71
  • [8] Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 do not account for the entire incretin effect in healthy humans
    Veedfald, S.
    Sun, Y.
    Xiang, C.
    Xie, C.
    Wu, T.
    Bound, M.
    Grivell, J.
    Hartmann, B.
    Jones, K.
    Horowitz, M.
    Holst, J. J.
    Rayner, C. K.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S48 - S48
  • [9] ELIMINATION AND DEGRADATION OF THE INCRETIN HORMONES GLUCAGON-LIKE PEPTIDE-1 AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE IN PATIENTS WITH END-STAGE RENAL DISEASE
    Idorn, Thomas
    Knop, Filip K.
    Jorgensen, Morten B.
    Christensen, Mikkel
    Holst, Jens J.
    Hornum, Mads
    Feldt-Rasmussen, Bo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 422 - 422
  • [10] Practical guide: Glucagon-like peptide-1 and dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonists in diabetes mellitus
    Alqifari, Saleh Fahad
    Alkomi, Omar
    Esmail, Abdullah
    Alkhawami, Khadijeh
    Yousri, Shahd
    Muqresh, Mohamad Ayham
    Alharbi, Nawwarah
    Khojah, Abdullah A.
    Aljabri, Ahmed
    Allahham, Abdulrahman
    Prabahar, Kousalya
    Alshareef, Hanan
    Aldhaeefi, Mohammed
    Alrasheed, Tariq
    Alrabiah, Ali
    Albishi, Laila A.
    WORLD JOURNAL OF DIABETES, 2024, 15 (03)